PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that develops ...

These novel luminescent labels should significantly enhance the sensitivity of all type of nucleic acid hybridization probes ... Your institution does not have access to this content. You can change ...

The change aims to improve safety standards and reduce infection risks, following concerns over the quality of certain blood ...

Telesis Bio has announced a licensing agreement with Regeneron, enabling the latter to deploy the Gibson SOLA platform at R&D ...